What is the standard management for febrile neutropenic fever?

What is the standard management for febrile neutropenic fever?

• A. Oral antibiotics at home
• B. Immediate hospital admission and IV broad-spectrum antibiotics
• C. Observation without antibiotics
• D. Antipyretics only

Answer: (B)

The main idea here is that fever in someone with very low neutrophils is a medical emergency that can deteriorate quickly, so the standard approach is to admit the patient and start intravenous broad-spectrum antibiotics right away. Neutropenia weakens the body’s ability to fight infections, and fever may be the first sign of a serious bacterial infection that can progress to sepsis if not treated promptly. Begin empiric IV therapy that covers Pseudomonas and other likely pathogens—agents such as piperacillin-tazobactam, cefepime, or a carbapenem are commonly used—and obtain cultures (blood, urine, and others as indicated) to guide de-escalation once results return. While some low-risk patients may be considered for outpatient oral therapy, the standard management for most febrile neutropenia is inpatient IV antibiotics due to the high risk of rapid progression. Other approaches that involve treating only with fever reducers or observation without antibiotics do not address the underlying infection risk in this setting.

The main idea here is that fever in someone with very low neutrophils is a medical emergency that can deteriorate quickly, so the standard approach is to admit the patient and start intravenous broad-spectrum antibiotics right away. Neutropenia weakens the body’s ability to fight infections, and fever may be the first sign of a serious bacterial infection that can progress to sepsis if not treated promptly. Begin empiric IV therapy that covers Pseudomonas and other likely pathogens—agents such as piperacillin-tazobactam, cefepime, or a carbapenem are commonly used—and obtain cultures (blood, urine, and others as indicated) to guide de-escalation once results return. While some low-risk patients may be considered for outpatient oral therapy, the standard management for most febrile neutropenia is inpatient IV antibiotics due to the high risk of rapid progression. Other approaches that involve treating only with fever reducers or observation without antibiotics do not address the underlying infection risk in this setting.